Click for best price
Newborn Screening for SMA SCID Market Size, Share 2024
| Market size in 2023 |
US$ 133 million
|
Forecast Market size by 2030 |
US$ 276.3 million
|
| Growth Rate |
CAGR of 11.0% |
Number of Pages |
65 Pages |
The global Newborn Screening for SMA and SCID market was valued at US$ 133 million in 2023 and is projected to reach US$ 276.3 million by 2030, at a CAGR of 11.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key players of newborn screening for SMA and SCID include Perkinelmer, Thermo Fisher, ImmunoIVD, Labsystems Diagnostics, etc. The top three players hold a share over 85%. North America is the largest market, has a share about 60%, followed by Europe, with share 25%.
Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn?t otherwise apparent at birth.
This report aims to provide a comprehensive presentation of the global market for Newborn Screening for SMA and SCID, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newborn Screening for SMA and SCID. This report contains market size and forecasts of Newborn Screening for SMA and SCID in global, including the following market information:
- Global Newborn Screening for SMA and SCID Market Revenue, 2019-2024, 2025-2030, ($ millions)
- Global top five companies in 2023 (%)
We surveyed the Newborn Screening for SMA and SCID companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Newborn Screening for SMA and SCID Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Newborn Screening for SMA and SCID Market Segment Percentages, by Type, 2023 (%)
Global Newborn Screening for SMA and SCID Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Newborn Screening for SMA and SCID Market Segment Percentages, by Application, 2023 (%)
- SCID Screening
- SMA Screening
Global Newborn Screening for SMA and SCID Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Newborn Screening for SMA and SCID Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Newborn Screening for SMA and SCID revenues in global market, 2019-2024 (estimated), ($ millions)
- Key companies Newborn Screening for SMA and SCID revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Perkinelmer
- Thermo Fisher
- ImmunoIVD
- Labsystems Diagnostics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Newborn Screening for SMA and SCID, market overview.
Chapter 2: Global Newborn Screening for SMA and SCID market size in revenue.
Chapter 3: Detailed analysis of Newborn Screening for SMA and SCID company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Newborn Screening for SMA and SCID in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Newborn Screening for SMA and SCID Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 133 million
|
| Forecast Market size by 2030 |
US$ 276.3 million
|
| Growth Rate |
CAGR of 11.0% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Newborn Screening for SMA and SCID Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Newborn Screening for SMA and SCID Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Newborn Screening for SMA and SCID Overall Market Size
2.1 Global Newborn Screening for SMA and SCID Market Size: 2023 VS 2030
2.2 Global Newborn Screening for SMA and SCID Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Newborn Screening for SMA and SCID Players in Global Market
3.2 Top Global Newborn Screening for SMA and SCID Companies Ranked by Revenue
3.3 Global Newborn Screening for SMA and SCID Revenue by Companies
3.4 Top 3 and Top 5 Newborn Screening for SMA and SCID Companies in Global Market, by Revenue in 2023
3.5 Global Companies Newborn Screening for SMA and SCID Product Type
3.6 Tier 1, Tier 2 and Tier 3 Newborn Screening for SMA and SCID Players in Global Market
3.6.1 List of Global Tier 1 Newborn Screening for SMA and SCID Companies
3.6.2 List of Global Tier 2 and Tier 3 Newborn Screening for SMA and SCID Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Newborn Screening for SMA and SCID Market Size Markets, 2023 & 2030
4.1.2 Instruments
4.1.3 Kits
4.1.4 Software
4.2 By Type - Global Newborn Screening for SMA and SCID Revenue & Forecasts
4.2.1 By Type - Global Newborn Screening for SMA and SCID Revenue, 2019-2024
4.2.2 By Type - Global Newborn Screening for SMA and SCID Revenue, 2025-2030
4.2.3 By Type - Global Newborn Screening for SMA and SCID Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Newborn Screening for SMA and SCID Market Size, 2023 & 2030
5.1.2 SCID Screening
5.1.3 SMA Screening
5.2 By Application - Global Newborn Screening for SMA and SCID Revenue & Forecasts
5.2.1 By Application - Global Newborn Screening for SMA and SCID Revenue, 2019-2024
5.2.2 By Application - Global Newborn Screening for SMA and SCID Revenue, 2025-2030
5.2.3 By Application - Global Newborn Screening for SMA and SCID Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Newborn Screening for SMA and SCID Market Size, 2023 & 2030
6.2 By Region - Global Newborn Screening for SMA and SCID Revenue & Forecasts
6.2.1 By Region - Global Newborn Screening for SMA and SCID Revenue, 2019-2024
6.2.2 By Region - Global Newborn Screening for SMA and SCID Revenue, 2025-2030
6.2.3 By Region - Global Newborn Screening for SMA and SCID Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Newborn Screening for SMA and SCID Revenue, 2019-2030
6.3.2 US Newborn Screening for SMA and SCID Market Size, 2019-2030
6.3.3 Canada Newborn Screening for SMA and SCID Market Size, 2019-2030
6.3.4 Mexico Newborn Screening for SMA and SCID Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Newborn Screening for SMA and SCID Revenue, 2019-2030
6.4.2 Germany Newborn Screening for SMA and SCID Market Size, 2019-2030
6.4.3 France Newborn Screening for SMA and SCID Market Size, 2019-2030
6.4.4 U.K. Newborn Screening for SMA and SCID Market Size, 2019-2030
6.4.5 Italy Newborn Screening for SMA and SCID Market Size, 2019-2030
6.4.6 Russia Newborn Screening for SMA and SCID Market Size, 2019-2030
6.4.7 Nordic Countries Newborn Screening for SMA and SCID Market Size, 2019-2030
6.4.8 Benelux Newborn Screening for SMA and SCID Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Newborn Screening for SMA and SCID Revenue, 2019-2030
6.5.2 China Newborn Screening for SMA and SCID Market Size, 2019-2030
6.5.3 Japan Newborn Screening for SMA and SCID Market Size, 2019-2030
6.5.4 South Korea Newborn Screening for SMA and SCID Market Size, 2019-2030
6.5.5 Southeast Asia Newborn Screening for SMA and SCID Market Size, 2019-2030
6.5.6 India Newborn Screening for SMA and SCID Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Newborn Screening for SMA and SCID Revenue, 2019-2030
6.6.2 Brazil Newborn Screening for SMA and SCID Market Size, 2019-2030
6.6.3 Argentina Newborn Screening for SMA and SCID Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Newborn Screening for SMA and SCID Revenue, 2019-2030
6.7.2 Turkey Newborn Screening for SMA and SCID Market Size, 2019-2030
6.7.3 Israel Newborn Screening for SMA and SCID Market Size, 2019-2030
6.7.4 Saudi Arabia Newborn Screening for SMA and SCID Market Size, 2019-2030
6.7.5 UAE Newborn Screening for SMA and SCID Market Size, 2019-2030
7 Newborn Screening for SMA and SCID Companies Profiles
7.1 Perkinelmer
7.1.1 Perkinelmer Company Summary
7.1.2 Perkinelmer Business Overview
7.1.3 Perkinelmer Newborn Screening for SMA and SCID Major Product Offerings
7.1.4 Perkinelmer Newborn Screening for SMA and SCID Revenue in Global Market (2019-2024)
7.1.5 Perkinelmer Key News & Latest Developments
7.2 Thermo Fisher
7.2.1 Thermo Fisher Company Summary
7.2.2 Thermo Fisher Business Overview
7.2.3 Thermo Fisher Newborn Screening for SMA and SCID Major Product Offerings
7.2.4 Thermo Fisher Newborn Screening for SMA and SCID Revenue in Global Market (2019-2024)
7.2.5 Thermo Fisher Key News & Latest Developments
7.3 ImmunoIVD
7.3.1 ImmunoIVD Company Summary
7.3.2 ImmunoIVD Business Overview
7.3.3 ImmunoIVD Newborn Screening for SMA and SCID Major Product Offerings
7.3.4 ImmunoIVD Newborn Screening for SMA and SCID Revenue in Global Market (2019-2024)
7.3.5 ImmunoIVD Key News & Latest Developments
7.4 Labsystems Diagnostics
7.4.1 Labsystems Diagnostics Company Summary
7.4.2 Labsystems Diagnostics Business Overview
7.4.3 Labsystems Diagnostics Newborn Screening for SMA and SCID Major Product Offerings
7.4.4 Labsystems Diagnostics Newborn Screening for SMA and SCID Revenue in Global Market (2019-2024)
7.4.5 Labsystems Diagnostics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Newborn Screening for SMA and SCID Market Opportunities & Trends in Global Market
Table 2. Newborn Screening for SMA and SCID Market Drivers in Global Market
Table 3. Newborn Screening for SMA and SCID Market Restraints in Global Market
Table 4. Key Players of Newborn Screening for SMA and SCID in Global Market
Table 5. Top Newborn Screening for SMA and SCID Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Newborn Screening for SMA and SCID Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Newborn Screening for SMA and SCID Revenue Share by Companies, 2019-2024
Table 8. Global Companies Newborn Screening for SMA and SCID Product Type
Table 9. List of Global Tier 1 Newborn Screening for SMA and SCID Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Newborn Screening for SMA and SCID Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Newborn Screening for SMA and SCID Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Newborn Screening for SMA and SCID Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Newborn Screening for SMA and SCID Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Newborn Screening for SMA and SCID Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Newborn Screening for SMA and SCID Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Newborn Screening for SMA and SCID Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2025-2030
Table 30. Perkinelmer Company Summary
Table 31. Perkinelmer Newborn Screening for SMA and SCID Product Offerings
Table 32. Perkinelmer Newborn Screening for SMA and SCID Revenue (US$, Mn) & (2019-2024)
Table 33. Perkinelmer Key News & Latest Developments
Table 34. Thermo Fisher Company Summary
Table 35. Thermo Fisher Newborn Screening for SMA and SCID Product Offerings
Table 36. Thermo Fisher Newborn Screening for SMA and SCID Revenue (US$, Mn) & (2019-2024)
Table 37. Thermo Fisher Key News & Latest Developments
Table 38. ImmunoIVD Company Summary
Table 39. ImmunoIVD Newborn Screening for SMA and SCID Product Offerings
Table 40. ImmunoIVD Newborn Screening for SMA and SCID Revenue (US$, Mn) & (2019-2024)
Table 41. ImmunoIVD Key News & Latest Developments
Table 42. Labsystems Diagnostics Company Summary
Table 43. Labsystems Diagnostics Newborn Screening for SMA and SCID Product Offerings
Table 44. Labsystems Diagnostics Newborn Screening for SMA and SCID Revenue (US$, Mn) & (2019-2024)
Table 45. Labsystems Diagnostics Key News & Latest Developments
List of Figures
Figure 1. Newborn Screening for SMA and SCID Segment by Type in 2023
Figure 2. Newborn Screening for SMA and SCID Segment by Application in 2023
Figure 3. Global Newborn Screening for SMA and SCID Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Newborn Screening for SMA and SCID Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Newborn Screening for SMA and SCID Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Newborn Screening for SMA and SCID Revenue in 2023
Figure 8. By Type - Global Newborn Screening for SMA and SCID Revenue Market Share, 2019-2030
Figure 9. By Application - Global Newborn Screening for SMA and SCID Revenue Market Share, 2019-2030
Figure 10. By Type - Global Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Newborn Screening for SMA and SCID Revenue Market Share, 2019-2030
Figure 12. By Application - Global Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Newborn Screening for SMA and SCID Revenue Market Share, 2019-2030
Figure 14. By Region - Global Newborn Screening for SMA and SCID Revenue Market Share, 2019-2030
Figure 15. By Country - North America Newborn Screening for SMA and SCID Revenue Market Share, 2019-2030
Figure 16. US Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Newborn Screening for SMA and SCID Revenue Market Share, 2019-2030
Figure 20. Germany Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2019-2030
Figure 21. France Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Newborn Screening for SMA and SCID Revenue Market Share, 2019-2030
Figure 28. China Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2019-2030
Figure 32. India Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Newborn Screening for SMA and SCID Revenue Market Share, 2019-2030
Figure 34. Brazil Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Newborn Screening for SMA and SCID Revenue Market Share, 2019-2030
Figure 37. Turkey Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Newborn Screening for SMA and SCID Revenue, (US$, Mn), 2019-2030
Figure 41. Perkinelmer Newborn Screening for SMA and SCID Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Thermo Fisher Newborn Screening for SMA and SCID Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. ImmunoIVD Newborn Screening for SMA and SCID Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Labsystems Diagnostics Newborn Screening for SMA and SCID Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
